Bicycle Therapeutics (BCYC) FCF Margin Growth (1y) (2019 - 2026)
Bicycle Therapeutics (BCYC) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -664,099.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -664,099.00 |
| Dec 31, 2025 | 22,178.00 |
| Sep 30, 2025 | 89,245.00 |
| Jun 30, 2025 | -202,851.00 |
| Mar 31, 2025 | -19,020.00 |
| Dec 31, 2024 | 62,467.00 |
| Sep 30, 2024 | -147,621.00 |
| Jun 30, 2024 | -77,796.00 |
| Mar 31, 2024 | 30,926.00 |
| Dec 31, 2023 | -50,994.00 |
| Sep 30, 2023 | 26,275.00 |
| Jun 30, 2023 | 92,560.00 |
| Mar 31, 2023 | -18,366.00 |
| Dec 31, 2022 | 38,238.00 |
| Sep 30, 2022 | -80,395.00 |
| Jun 30, 2022 | 7,371.00 |
| Mar 31, 2022 | -1,456.00 |
| Dec 31, 2021 | -31,602.00 |
| Sep 30, 2021 | 77,503.00 |
| Jun 30, 2021 | 10,264.00 |